This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Stock Market News for Sep 17, 2025
by Zacks Equity Research
U.S. stocks ended lower on Tuesday in a choppy trading session, as investors remained cautious ahead of the Federal Reserve's decision on interest rates at the end of its two-day policy meeting on Wednesday.
UnitedHealth Group (UNH) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
UnitedHealth Group (UNH) reached $339.58 at the closing of the latest trading day, reflecting a -2.39% change compared to its last close.
OppFi and UnitedHealth have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Zacks names OppFi its Bull of the Day with earnings momentum and sector strength, while UnitedHealth faces probe, rising costs, and a sharp stock decline.
Bear of the Day: UnitedHealth Group (UNH)
by Bryan Hayes
Recent positives mask deeper structural, operational, and regulatory vulnerabilities.
UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $347.89, denoting a -1.31% move from the preceding trading day.
UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus
by Abhinab Dasgupta
Zacks' strategies continue to outpace the market in 2025, with standout gains from CommScope, Micron, Oracle, and others across multiple model portfolios.
Will UnitedHealth's Push for Access to Trump Calm Investor Jitters?
by Kaibalya Pravo Dey
UNH doubles lobbying spend, reshapes legal team and seeks Trump access amid regulatory risks.
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
by Kaibalya Pravo Dey
ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.
CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?
by Moumi Mondal
CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.
Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares
by Zacks Equity Research
HUM scoops up $68M Florida care centers, but star rating hurdles send shares tumbling 12%. Can HUM turn risk into reward?
UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points
by Kaibalya Pravo Dey
UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.
The Zacks Analyst Blog Highlights Nebius, Microsoft, UnitedHealth, Apple and Oracle
by Zacks Equity Research
Nebius, Microsoft, UnitedHealth, Apple, and Oracle drive market buzz as AI deals, Medicare gains, and cloud growth shake up stocks.
Stock Market News for Sep 10, 2025
by Zacks Equity Research
Wall Street closed higher on Tuesday, driven by utilities and healthcare stocks.
Oracle Misses in Q3, Gains +22% - Plus Jobs Revisions & More
by Mark Vickery
While Oracle missed on Q3 revenues it grew +55% in Cloud Infrastructure year over year.
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?
by Kaibalya Pravo Dey
UNH reaffirms its 2025 EPS outlook, but mounting costs, legal probes and valuation pressures cloud the path ahead.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw UnitedHealth Group (UNH) settling at $320.37, representing a +1.58% change from its previous close.
UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?
by Zacks Equity Research
UNH is leveraging AI to streamline insurance and care delivery, aiming to boost efficiency and improve patient outcomes.
CVS Health Trades Cheaper Than Industry: How to Play the Stock?
by Moumi Mondal
CVS' diversified model, digital push and Aetna stabilization highlight a compelling investment story.
5 Best-Performing Sector ETFs of August
by Sanghamitra Saha
Marijuana, crypto, materials, healthcare and space ETFs led August gains despite tech volatility. These ETFs are MSOS, REMX, IHF, UFO, and ETHW.
Cyberattack Hangover: Senators Question UnitedHealth's Loan Playbook
by Kaibalya Pravo Dey
Senators question UNH over tough loan repayment demands post-cyberattack, adding to regulatory and cost pressures.
Is ELV's Push Beyond Insurance a Blueprint for the Healthcare Future?
by Zacks Equity Research
Elevance Health expands beyond insurance into primary care, digital health and pharmacy services, aiming to reshape healthcare delivery.
Wall Street Analysts See UnitedHealth (UNH) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Why Is UnitedHealth (UNH) Up 14.2% Since Last Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UnitedHealth Group (UNH) Laps the Stock Market: Here's Why
by Zacks Equity Research
UnitedHealth Group (UNH) closed the most recent trading day at $303.96, moving +1.17% from the previous trading session.